Skip to main content
. 2023 Sep 3;10(30):2303872. doi: 10.1002/advs.202303872
Human BAK reverse: 5′‐ GTAGCCGAAGCCCAGAAG −3′;
Human LAT2 forward: 5′‐ GAAGCCTACATAGACCCCATTG −3′;
Human LAT2 reverse: 5′‐ CTCTGTGGTTTTCTGCTTGC −3′;
Human FASN forward: 5′‐ CAAGCTGAAGGACCTGTCTAG −3′;
Human FASN reverse: 5′‐ CGGAGTGAATCTGGGTTGATG −3′;
Human MYC forward: 5′‐ TTCGGGTAGTGGAAAACCAG −3′;
Human MYC reverse: 5′‐ AGTAGAAATACGGCTGCACC −3′;
Human EGFR forward: 5′‐ AAGCCATATGACGGAATCCC −3′;
Human EGFR reverse: 5′‐ GGAACTTTGGGCGACTATCTG −3′;
Human TP53 forward: 5′‐ GCCATCTACAAGCAGTCACAG −3′;
Human TP53 reverse: 5′‐ GCCATCTACAAGCAGTCACAG −3′;
Human TGF‐β forward: 5′‐ GCCTTTCCTGCTTCTCATGG −3′;
Human TGF‐β reverse: 5′‐ TCCTTGCGGAAGTCAATGTAC −3′;